Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2003
04/02/2003CN1104251C Osteomyelitis treating medicine
04/02/2003CN1104248C Chinese medicine for treating tuberculosis and hepatitis
04/02/2003CN1104247C Suppository for treating cervical erosion and vaginitis
04/02/2003CN1104246C Fumigant lotion for treating anorectal disease and preparing process thereof
04/02/2003CN1104191C Method and apparatus for treating body fluid
04/01/2003US6542910 Systems and methods for storing, retrieving, and manipulating data in medical processing devices
04/01/2003US6541616 Exterior membrane; nucleotide sequence; induction immunology response
04/01/2003US6541256 Growth medium for human corneal endothelial cells
04/01/2003US6541255 Engraftable human neural stem cells
04/01/2003US6541248 Genome comprising nucleotide sequence encoding an anti-sense RNA or ribozyme; cleavage of a second nucleotide sequence which encodes a polypeptide; use in gene therapy
04/01/2003US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion
04/01/2003US6541219 Therapeutic Gene
04/01/2003US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease
04/01/2003US6541041 Crude drug extracts, and methods for making and standardizing same
04/01/2003US6541036 Placing tumor cells in culture in vitro or ex vivo supplemented with pro-apoptotic agent, transferring tumor cells into diffusion chamber, inserting chamber into human for therapeutically effective time
04/01/2003US6541028 Methods for promoting healing of corneal resurfacing wounds
04/01/2003US6541027 Lactic acid bacteria with anxiolytic properties and uses thereof
04/01/2003US6541024 Regeneration and augmentation of bone using mesenchymal stem cells
04/01/2003US6541010 Alphavirus RNA replicon systems
04/01/2003US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier
04/01/2003US6540998 Method for producing a nematocidal composition by heat treating a pH-adjusted fermentation broth
04/01/2003US6540995 Administering into the solid tumor of a cancer patient, a capsule encapsulating cytochrome P450 producing cells, and the capsule containing a porous membrane to protect the cells from immune system, allows prodrug to pass into the capsule
04/01/2003US6540994 Administering to a cancer patient, a macrophase produced by culturing monocytes in vitro, and macrophages having specific properties, such as, cytotoxic acitivity without IFN-gamma is increased by 20-30% with respect to standard macrophages
04/01/2003US6540967 Apparatus for the irradiation of a liquid
04/01/2003CA1341426C Process for the manufacture of thrombin inhibitors
03/2003
03/27/2003WO2003025191A2 Pseudotyped retroviral vector system
03/27/2003WO2003025190A1 Tumor-specific promoter and use thereof
03/27/2003WO2003025151A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
03/27/2003WO2003025149A2 Cell populations which co-express cd49c and cd90
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003024989A2 Activation and expansion of cells
03/27/2003WO2003024479A1 Enamel matrix protein compositions for modulating immune response
03/27/2003WO2003024472A2 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
03/27/2003WO2003024471A2 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
03/27/2003WO2003024463A1 Stratified cartilage tissue and methods to engineer same
03/27/2003WO2003024462A1 Cardiac transplantation of stem cells for the treatment of heart failure
03/27/2003WO2003024406A2 Nestin-expressing hair follicle stem cells
03/27/2003WO2003024312A2 Cell therapy system
03/27/2003WO2003024297A2 Cell storage and delivery system
03/27/2003WO2002092054A3 Immune modulation device for use in animals
03/27/2003WO2002090551A3 Self-containing lactococcus strain
03/27/2003WO2002088330A8 Neural progenitor cells
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002024640A3 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
03/27/2003WO2002004006A3 Method for improving the efficacy of artificial insemination of non-human animals
03/27/2003US20030060442 Immunostimulatory cyktokines include interleukins as antitumor agents, dervived from dendritic cells modified via viral vector transduction/centrifugation
03/27/2003US20030059943 Inhibition of gene expression in preferential cell; obtain cells, infect with viral particles, recover infected cells, express viral sequences, monitor adjustment in gene expression
03/27/2003US20030059939 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/27/2003US20030059938 Presenilin-deficient multipotent cell lines and screening methods for intramembrane-regulated proteolytic activities using these lines
03/27/2003US20030059933 Apparatus for use in the propagation of tissues
03/27/2003US20030059868 Retinal cell lines with extended life-span and their applications
03/27/2003US20030059864 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
03/27/2003US20030059799 Modified DNA molecule, recombinant containing the same, and uses thereof
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059742 Osteointegration device and method
03/27/2003US20030059479 A cell activating agent comprising a royal jelly and alpha, alpha- trehalose which acts as a stabilizer and preservative at low temperatures; tonic, health food or health supplement; cosmetics
03/27/2003US20030059478 Aqueous extract of the plant Soma; a mixture of milk, plant derivatives and a mineral comprising apple cider vinegar, quinine, blackstrap molasses, sulfur and whole milk; anticarcinogenic and -tumor agents
03/27/2003US20030059477 Basic cell growth stimulating factors from a mammal milk product having basic to neutral isoelectric points, enriched with proliferation stimulant of rat myoblasts; wound healing agents for gastrointestinal injuries and skin
03/27/2003US20030059475 Fibrin microbeads and uses thereof
03/27/2003US20030059457 Phaseolamin compositions and methods for using the same
03/27/2003US20030059442 Attenuated microorganisms for the treatment of infection
03/27/2003US20030059433 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor
03/27/2003US20030059426 Method for inducing selectively suppressed immune response to transplanted tissue or cells
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059415 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003US20030059414 Cell populations which co-express CD49c and CD90
03/27/2003US20030059412 Fot treatment of disorders of bone cartilage or lung defect (such as osteoporosis and cycstic fibrosis) via transfection comprising herpes thymidine kinase gene
03/27/2003US20030059408 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003US20030059403 Phaseolamin compositions and methods for using the same
03/27/2003US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression
03/27/2003US20030058888 Multiplex transmission system and multiplex transmitter
03/27/2003CA2709442A1 Cell populations which co-express cd49c and cd90
03/27/2003CA2465672A1 Cardiac transplantation of stem cells for the treatment of heart failure
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460539A1 Stratified cartilage tissue and methods to engineer same
03/27/2003CA2460184A1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459587A1 Activation and expansion of cells
03/26/2003EP1295535A2 Phaseolamin compositions and methods for using the same
03/26/2003EP1295126A2 Hepatitis c viral antigen immunoassay detection systems
03/26/2003EP1294918A2 Replication deficient adenoviral tnf vector
03/26/2003EP1294857A2 Genetically modified t-cells, method for producing them and use thereof
03/26/2003EP1294851A2 Siderophores-producing bifidobacteria thereby and uses thereof
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294759A1 Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294293A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa
03/26/2003EP0981379B1 Artificial bodily fluid
03/26/2003EP0946186B1 Stomach submucosa derived tissue graft
03/26/2003CN1406276A Sericin-containing material, Process for producing the same and method of using the same
03/26/2003CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7
03/26/2003CN1406245A Method of eliminating human serum albumin polymers
1 ... 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 ... 1259